SciTransfer
Organization

NECTON-COMPANHIA PORTUGUESA DE CULTURAS MARINHAS SA

Portuguese microalgae production company supplying biomass and ingredients for food, feed, cosmetics, and emerging health applications.

Technology SMEfoodPTSME
H2020 projects
4
As coordinator
0
Total EC funding
€1.7M
Unique partners
88
What they do

Their core work

Necton is a Portuguese private company specializing in the commercial cultivation of microalgae and macroalgae. They produce algae-based ingredients for food, animal feed, cosmetics, and increasingly for health applications. With deep expertise in marine cultivation at industrial scale, they serve as a key biomass supplier and process partner in EU-funded projects that aim to turn algae into high-value protein, nutritional, and bioactive compounds.

Core expertise

What they specialise in

Algae-based food and feed ingredientsprimary
3 projects

MAGNIFICENT, ProFuture, and Algae4IBD all target protein extraction, nutritional ingredients, and functional food from algae.

Sustainable protein productionsecondary
2 projects

ProFuture and MAGNIFICENT explicitly focus on algae as a sustainable alternative protein source for food and feed systems.

Microbiome and functional health applicationsemerging
2 projects

SIMBA addresses microbiome applications in food systems, while Algae4IBD explores algae-derived compounds for inflammatory bowel disease prevention and treatment.

Macroalgae (seaweed) bioactivesemerging
1 project

Algae4IBD (2021) includes macroalgae alongside microalgae, signaling expansion beyond their traditional microalgae focus.

Evolution & trajectory

How they've shifted over time

Early focus
Microalgae ingredients for food/cosmetics
Recent focus
Algae protein and health bioactives

Necton's early H2020 involvement (2017–2018) focused on broad applications of microalgae as ingredients for food, feed, and cosmetics (MAGNIFICENT, SIMBA). From 2019 onward, their work sharpened toward two directions: sustainable protein production from microalgae (ProFuture) and health-oriented bioactives for conditions like inflammatory bowel disease (Algae4IBD). This shift from general ingredient supply toward targeted health and nutrition applications reflects a clear move up the value chain.

Necton is moving from bulk algae ingredient supply toward high-value health and therapeutic applications, making them an increasingly relevant partner for pharma-food crossover projects.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European21 countries collaborated

Necton participates exclusively as a partner, never as coordinator, which is typical for a production-focused SME that brings cultivation infrastructure and biomass expertise to larger consortia. Their 88 unique partners across 21 countries indicate they are well-networked and comfortable in large, multi-national consortia (averaging 22 partners per project). This suggests they are a reliable, low-friction partner who integrates smoothly into big collaborative efforts.

Necton has collaborated with 88 distinct partners across 21 countries, giving them one of the broader networks you'd expect from a specialized SME. Their connections span the European algae and food innovation ecosystem extensively.

Why partner with them

What sets them apart

Necton is one of the few European companies that combines commercial-scale microalgae production facilities with active R&D participation. Unlike university labs that grow algae at bench scale, Necton operates real production infrastructure in the Algarve region of Portugal, meaning they can supply biomass and validate processes under industrial conditions. For consortium builders, they fill a critical gap: the company that can actually grow, harvest, and process the algae that others want to study or formulate.

Notable projects

Highlights from their portfolio

  • MAGNIFICENT
    Largest EC contribution (EUR 771,250) and their first major H2020 project, establishing Necton's role as a microalgae supplier for food, feed, and cosmetics ingredients.
  • Algae4IBD
    Marks Necton's strategic expansion into therapeutic health applications, connecting algae bioactives to inflammatory bowel disease treatment — a significant leap from food ingredients.
  • ProFuture
    Directly addresses the alternative protein challenge with EUR 435,531, positioning microalgae as a future-proof protein source for food and feed systems.
Cross-sector capabilities
Health & pharma (algae-derived bioactives for gut health)Cosmetics & personal care (microalgae-based ingredients)Aquaculture & marine biotechnologyEnvironmental sustainability (low-impact protein production)
Analysis note: Four projects with clear thematic consistency provide a solid profile. Necton's website (necton.pt) and commercial operations are well-documented. The only limitation is the absence of coordinator roles, which means we see them through consortium lenses rather than their own project design choices.